Nucleix Ltd.

Industry · 10 registered clinical trials — 2 currently recruiting.

Status	Trial	Phase	Started
Recruiting	Bladder EpiCheck Product Development Study Suspicion of Bladder Cancer, NMIBC Surveillance	—	2025-09-15
Recruiting	Bladder EpiCheck European Haematuria Study Hematuria, Cystoscopy, Urothelial Carcinoma Bladder	—	2025-06-20
Unknown	Lung EpiCheck Biomarkers Development Study Lung Cancer	—	2022-05-17
Active Not Recruiting	Determination and Validation of a Multi-analyte Assay for Lung Cancer Screening Lung Cancer	—	2021-09-17
Completed	Analytical Specificity of Bladder EpiCheck Test in Healthy Population and Urology Patients Without Prior Histo Non Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Urothelial Carcinoma	—	2019-09-05
Completed	Characterization of Methylation Patterns in Cancer and Non-Cancer cfDNA Cancer, Solid Tumor, Hematologic Neoplasms	—	2019-04-17
Terminated	Characterization of Methylation Patterns in Hepatocellular Carcinoma Hepatocellular Carcinoma, Hepatocellular Cancer, Cirrhosis	—	2018-02-13
Completed	The Efficacy of the Bladder EpiCheck for Detection of Recurrent Urothelial Cell Carcinoma Bladder Cancer	N/A	2016-09-01
Completed	Utility of Bladder EpiCheck for Detection of Recurrent Urothelial Carcinoma Bladder Cancer	N/A	2015-12-01
Completed	Characterization of Methylation Patterns in Lung Cancer Lung Cancer	—	2015-02-01